Celecoxib: a new augmentation strategy for depressive mood episodes. A systematic review and meta‐analysis of randomized placebo‐controlled trials

F Faridhosseini, R Sadeghi, L Farid… - Human …, 2014 - Wiley Online Library
Objective The aim of this research was to perform a systematic review to identify all
randomized controlled trials (RCTs) evaluating the efficacy and safety of add‐on celecoxib …

Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis

KS Na, KJ Lee, JS Lee, YS Cho, HY Jung - Progress in Neuro …, 2014 - Elsevier
Background Numerous studies have reported that inflammation is closely associated with
depression, and adjunctive non-steroidal anti-inflammatory drug (NSAID) treatment has …

Celecoxib for mood disorders: a systematic review and meta-analysis of randomized controlled trials

A Gędek, Z Szular, AZ Antosik, P Mierzejewski… - Journal of Clinical …, 2023 - mdpi.com
The effects of celecoxib on a broad spectrum of mood disorders and on inflammatory
parameters have not yet been comprehensively evaluated. The aim of this study was to …

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial

S Akhondzadeh, S Jafari, F Raisi… - Depression and …, 2009 - Wiley Online Library
Background: The pathophysiology of depression is associated with the hyperactivity of
immune inflammatory responses. Cyclooxygenase‐2 inhibitors such as celecoxib reduce …

[HTML][HTML] Effect of celecoxib on improving depression: A systematic review and meta-analysis

Z Wang, Q Wu, Q Wang - World Journal of Clinical Cases, 2022 - ncbi.nlm.nih.gov
BACKGROUND Anti-inflammation drugs were uncovered to be a potential therapy for
depression. Celecoxib as a selective COX2 inhibitor is also one anti-inflammation drugs …

No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: a 6-week double-blind placebo controlled randomized trial

BT Baune, E Sampson, J Louise, H Hori… - European …, 2021 - Elsevier
Given the role of low-grade inflammation in the pathophysiology of major depressive
disorder (MDD), anti-inflammatory strategies may improve treatment outcomes in some …

Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double‐blind, randomized, placebo‐controlled study

FG Nery, ES Monkul, JP Hatch… - Human …, 2008 - Wiley Online Library
Objective To investigate whether the cox‐2 inhibitor celecoxib has antidepressant effects in
bipolar disorder (BD) patients during depressive or mixed phases. Methods We studied 28 …

Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials

O Köhler, ME Benros, M Nordentoft, ME Farkouh… - JAMA …, 2014 - jamanetwork.com
Importance Several studies have reported antidepressant effects of anti-inflammatory
treatment; however, the results have been conflicting and detrimental adverse effects may …

Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo …

SH Abbasi, F Hosseini, A Modabbernia… - Journal of affective …, 2012 - Elsevier
BACKGROUND: It has been proposed that the mechanism of the antidepressant effect of
celecoxib is linked to its anti-inflammatory action and particularly its inhibitory effect on pro …

[HTML][HTML] Efficacy of celecoxib add-on treatment for immuno-metabolic depression: Protocol of the INFLAMED double-blind placebo-controlled randomized controlled …

JC Zwiep, PM Bet, D Rhebergen… - Brain, behavior, & …, 2023 - Elsevier
Introduction As the role of (neuro) inflammation in depression pathophysiology is emerging,
augmentation of antidepressant treatments with anti-inflammatory drugs have shown …